AngioTrax Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

AngioTrax General Information

Description

Developer of medical devices for cardiac revascularization. The company develops novel medical devices which help in providing new, additional or augmented blood supply to a patients heart.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 743 North Pastoria
  • Sunnyvale, CA 94086
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AngioTrax Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 01-Dec-2000 00.00 Completed Startup
2. Early Stage VC (Series B) 01-May-1998 00.00 Completed Startup
1. Early Stage VC (Series A) 03-Jul-1997 $1.6M $1.6M 00.00 Completed Startup
To view AngioTrax’s complete valuation and funding history, request access »

AngioTrax Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 0,000,000 00.000000 00.0 00 00 00 00
Series A 0,000,000 00.000000 00.0 00 00 00 00 00.000
To view AngioTrax’s complete cap table history, request access »

AngioTrax Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Delphi Ventures Venture Capital Minority 000 0000 000000 0
IVP Venture Capital Minority 000 0000 000000 0
ONSET Ventures Venture Capital Minority 000 0000 000000 0
To view AngioTrax’s complete investors history, request access »